RB1 and neoplasm: Our previous research has identified bisacridine derivative A06 as a dual-targeting ligand capable of disrupting both G4 and i-motif structures on the promoter of tumor suppressor gene retinoblastoma (RB), consequently increasing RB expression significantly and inhibiting tumor proliferation and metastasis [22].